homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


print  email to a friend  reprints add to mydjc  

August 26, 2021

Visus Therapeutics

Visus Therapeutics, a clinical-stage pharmaceutical company developing ophthalmic therapies, appointed Tracy Valorie and Dwight Moxie to its board. Valorie brings 25 years of experience in the pharmaceutical and biotech industries spanning strategic business counsel, commercial development, brand and customer marketing, and clinical development and research. She previously was senior vice president and general manager of US Ophthalmology Rx and Surgical at Bausch + Lomb. Prior to that, she held numerous leadership positions at Pfizer. Moxie is the general counsel, senior vice president and corporate secretary at Revance Therapeutics. He leads legal, governance and compliance for the company, and brings more than two decades of experience in the biopharmaceutical and health care sectors. Visus has offices in Seattle and Orange County, California.




Email or user name:
Password:
 
Forgot password? Click here.